Tallahassee, FL, United States of America

Kaixian Yu

This inventor holds 1 USPTO granted patent. Top assignee: Innomedicine, LLC. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kaixian Yu. Retrieved from https://idiyas.com/inventor/kaixian-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kaixian Yu: Innovator in Chemotherapy Regimen Selection

Introduction

Kaixian Yu is a notable inventor based in Tallahassee, FL (US). He has made significant contributions to the field of medicine, particularly in the area of chemotherapy regimen selection. His innovative work has the potential to improve treatment outcomes for patients undergoing chemotherapy.

Latest Patents

Kaixian Yu holds a patent for a chemotherapy regimen selection. This invention provides kits for selecting a chemotherapy regimen for a subject. The kits include components for detecting the expression of various genes, which are crucial for determining the most effective treatment options. His patent is a valuable addition to the medical field, as it offers methods for personalized chemotherapy treatment.

Career Highlights

Yu is associated with Innomedicine, LLC, where he continues to develop innovative solutions in healthcare. His work focuses on enhancing the efficacy of chemotherapy through genetic analysis, which can lead to more tailored and effective treatment plans for patients.

Collaborations

Kaixian Yu collaborates with talented individuals such as Jinfeng Zhang and Amy Qingxiang Sang. These partnerships foster a creative environment that encourages the development of groundbreaking medical technologies.

Conclusion

Kaixian Yu's contributions to chemotherapy regimen selection exemplify the importance of innovation in medicine. His work not only advances scientific knowledge but also has the potential to significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…